Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion type Assertion NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_head.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion description "[The MAL gene, which has been shown to confer resistance to cancer therapy, was most highly overexpressed in short-term survivors (3-fold compared with long-term survivors, and 29-fold compared with early-stage cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_provenance.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion evidence source_evidence_literature NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_provenance.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion SIO_000772 15897565 NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_provenance.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion wasDerivedFrom befree-20150227 NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_provenance.
- NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_assertion wasGeneratedBy ECO_0000203 NP289590.RABRjmHcD8QqvUiRHPkJoJj3g66VTsYzJ8-7z6gt2H4nw130_provenance.